Nothing has changed from what they said in August, why would it.
A small amount of product has been produced recently to facilitate FDA required clinical studies and distribution trials during FY24.
And from the FY 24 outlook - The Company expects growth in other nutritional products and modest growth in ANZ and USA liquid milk. USA IMF sales are expected to be immaterial.
Nothing has changed from what they said in August, why would...
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.72 |
Change
-0.270(3.86%) |
Mkt cap ! $4.858B | |||
| Open | High | Low | Value | Volume |
| $6.96 | $6.98 | $6.63 | $20.41M | 3.023M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 50927 | $6.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.72 | 11848 | 3 |
View Market Depth
| Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$6.67 |
Change
-0.270 ( 4.62 %) |
||||
| Open | High | Low | Volume | ||
| $6.97 | $6.98 | $6.63 | 1304757 | ||
| Last updated 15.59pm 17/06/2024 ? | |||||
| A2M (ASX) Chart |
